European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data | PLOS ONE
Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Fibromax
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. - Abstract - Europe PMC
Nonalcoholic Fatty Liver Disease: Diagnosis and Management | AAFP
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
BioPredictive · FibroMax
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - ScienceDirect
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers - ScienceDirect
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
